United States Federal Circuit
Fresenius USA, Inc. v. Baxter International, Inc., 12-1334
The cancellation of the asserted claims of defendant's '434 patent, which teaches the use of a dialysis machine with an integrated touch screen interface, by the PTO, pursuant to the agency's statutory reexamination authority, must be given effect in this pending infringement litigation, and therefore the district court's judgment that the '434 patent was valid and plaintiff infringed said patent, is vacated and remanded.
Appellate Information
- Decided 07/02/2013
- Published 07/02/2013
Judges
- DYK
Court
- United States Federal Circuit